VXRT (Vaxart, Inc.) Gross Margin

Corporate emblem and logo of Vaxart, Inc. (VXRT)

Geopolitical tensions and pandemic risks are increasing government funding for Vaxart, Inc. (VXRT) developments, which strengthens the company's credit profile. The average gross margin demonstrates pricing stability, with the 0.00 metric serving as the target level. Financial stability relies on the creation of tablet vaccines for government agencies and high demand in regions with weak cold-chain logistics.

VXRT (vaxart.com) Return on Gross Profit history from 07/04/2022 to 07/19/2025

Financial and market metric breakdowns for Vaxart, Inc. (VXRT)

- business market valuation indicators:
Basic company analysis:Vaxart, Inc.
Manufactured products of Vaxart Corp

Gross margin measures the portion of revenue remaining after covering direct production costs, allowing for an assessment of cost management efficiency. An analysis of the operating gross margin reveals hidden yield compression and the risk of capital freezing prior to the publication of financial statements. For Vaxart, Inc. (VXRT), the high stability of this metric is driven by its oral vaccine platform, which simplifies logistics and generates steady licensing royalties.